SCHEMBL6311752

SCHEMBL6311752

CC(C)C1CNc2c(oc3ccc([N+](=O)[O-])cc23)C(=O)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.40
PNMT P11086 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
CA9 Q16790 2/20 0.40
CA12 O43570 1/20 0.40
POLB P06746 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
GABRP O00591 3/20 0.39
GABRD O14764 3/20 0.39
GABRA1 P14867 3/20 0.39
GABRB1 P18505 3/20 0.39
GABRG2 P18507 3/20 0.39
GABRB3 P28472 3/20 0.39
GABRA5 P31644 3/20 0.39
GABRA3 P34903 3/20 0.39
GABRA2 P47869 3/20 0.39
GABRB2 P47870 3/20 0.39
GABRA4 P48169 3/20 0.39
GABRE P78334 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311742 1.00 ADRA2A (0.40) ADRA2APNMTADRA2BADRA2CCA9
SCHEMBL6313910 0.86 CDK1 (0.43) ADRA2APNMTADRA2BADRA2CCA9
SCHEMBL6313915 0.86 CDK1 (0.43) ADRA2APNMTADRA2BADRA2CCA9
SCHEMBL6314193 0.86 CDK1 (0.43) ADRA2APNMTADRA2BADRA2CCA9
SCHEMBL6320291 0.78 CA12 (0.46) CA9CA12POLBTDP1GABRP
SCHEMBL6311214 0.77 CA12 (0.43) CA9CA12POLBTDP1GABRP
SCHEMBL9189119 0.64 KDM1A (0.61) CA9CA12POLBTDP1GABRP
SCHEMBL17676644 0.62 CDC7 (0.36) TDP1MAPTKMT2AALDH1A1CASP7
SCHEMBL4924117 0.62 ALDH1A1 (0.56) CA9CA12TDP1GABRPGABRD
SCHEMBL29197451 0.62 GABRP (0.55) CA9CA12POLBTDP1GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050250765-A1 Diazepinones as antiviral agents CHO HIDETSURA 2005-11-10 US claimed
US-20040116410-A1 Diazepinones as antiviral agents CHO HIDETSURA (JP) 2004-06-17 US claimed
US-20050250765-A1 Diazepinones as antiviral agents CHO HIDETSURA 2005-11-10 US disclosed
US-20040116410-A1 Diazepinones as antiviral agents CHO HIDETSURA (JP) 2004-06-17 US disclosed
WO-2002014324-A2 DIAZEPINONES AS ANTIVIRAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250765-A1 Diazepinones as antiviral agents ZC3HAV1, ECI1, ZC3HAV1L ADRA2A 3567/4885PNMT 2732/4885ADRA2B 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.